Mirexus
  • Home
  • Company
    • History
    • Supporting Organizations
    • Board & Management
    • Government R&D Investments
    • AODA
  • Phytoglycogen
    • What is Nanotechnology?
    • Phytoglycogen Product Information
    • Safe & Natural Nanotechnology
    • Publications
  • Businesses
    • Mirexus Inc.
    • Glysantis Inc.
  • News & Events
    • Gallery
  • Contact Us
Select Page

Mirexus’ Founder Dr. John Dutcher Receives University of Guelph Innovations of the Year Award.

by Mirexus Biotech | Jul 10, 2017

Mirexus’ founder and physics professor Dr. John Dutcher received the University of Guelph Innovations of the Year Award for his work with nanoparticles. Mirexus’ platform material PhytoSpherix™,  ,which is a natural biopolymer extracted in the form of completely...

Mirexus Biotechnologies Inc. raises $12 million to finance factory, fund business development, and deepen R&D

by Mirexus Biotech | Jun 29, 2017

Guelph, ON – June 29, 2017 Mirexus Biotechnologies Inc. (Mirexus) is excited to announce that it has closed an investment round of $12 million.  Mirexus is a safe and natural nanomaterials company based in Guelph, Ontario that is commercializing PhytoSpherix™, a novel...

Dr. Karl Klinger receives Talent Edge postdoctoral research award from the Ontario Centres of Excellence

by Mirexus Biotech | Jun 15, 2017

Mirexus is pleased to announce that Dr. Karl Klinger has recently received an OCE Talent Edge postdoctoral research award. The OCE (Ontario Centres of Excellence) Talent Edge award provides 1 year of research funding in industry for top recent PhD graduates. Karl has...

Boris Segalowitch joins Mirexus as Vice President Personal Care

by Mirexus Biotech | Jun 1, 2017

Mirexus is pleased to announce that Boris Segalowitch has joined as Vice President Personal Care. Boris is based in Paris, France and will lead our efforts to expand the use of our innovative products into the Global Personal Care market. Boris brings over 20 years’...

Mirexus Biotechnology to Present at the Biophysical Society of Canada in Montreal, Quebec on 24th-26th May 2017.

by Mirexus Biotech | Mar 30, 2017

MIREXUS is pleased to announce that we will be Presenting at the 3rd Annual Meeting of the Biophysical Society of Canada to be held in Montreal, Quebec from May 24-26, 2017. Dr. Marty Kurylowicz (R&D Manager) will be presenting on “Applications of Phytoglycogen...

Mirexus to Present & Exhibit at the Sustainable Cosmetics Summit in New York on 4th-5th May 2017.

by Mirexus Biotech | Mar 29, 2017

MIREXUS is pleased to announce that we will be Presenting & Exhibiting at the Sustainable Cosmetics Summit in New York on 4th-5th May 2017. Dr. Marty Kurylowicz (R&D Manager) will be presenting in the Novel Green Ingredients Session (May 4th at 4pm) on...
« Older Entries
Next Entries »

Contact Us

Dr. Phil Whiting

President & CEO

Mirexus Biotechnologies Inc.

pwhiting@mirexus.com

Cell: +1 (905) 339 9907

Mirexus Biotechnologies Inc.

574 Hanlon Creek Boulevard

Guelph, ON N1C 0A1

Phone: +1 (519) 829 1221

Mirexus Biotechnologies Inc. is ISO 9001:2015 Certified.

Mirexus Biotechnologies Inc. is
ISO 9001:2015 certified.

Partner

green-sky-e1407192700124

News & Events

  • Mirexus Biotechnologies is now an Industrial member of Nano Ontario.
  • Mirexus’ phytoglycogen designated as Generally Recognized As Safe (GRAS) by an external expert panel.
  • Alison Crumblehulme Promoted to Chief Operating Officer of Mirexus Biotechnologies Inc.
2019 © Mirexus . All Rights Reserve